APA (7th ed.) Citation

SA, M., E, H., AM, K., C, N., FL, K., C, Y., . . . RS, H. (2023). Transmissible SARS-CoV-2 variants with resistance to clinical protease inhibitors. Science advances, 9(13), eade8778. https://doi.org/10.1126/sciadv.ade8778

Chicago Style (17th ed.) Citation

SA, Moghadasi, et al. "Transmissible SARS-CoV-2 Variants with Resistance to Clinical Protease Inhibitors." Science Advances 9, no. 13 (2023): eade8778. https://doi.org/10.1126/sciadv.ade8778.

MLA (9th ed.) Citation

SA, Moghadasi, et al. "Transmissible SARS-CoV-2 Variants with Resistance to Clinical Protease Inhibitors." Science Advances, vol. 9, no. 13, 2023, p. eade8778, https://doi.org/10.1126/sciadv.ade8778.